Annual Report FY26 filed, 37th AGM on Aug 20 with Rs.10 dividend
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.8 pts less than Nifty Microcap 250 and 5.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Venus Remedies filed FY 2025-26 Annual Report and 37th AGM notice for August 20, 2026 via video conferencing. Items include adoption of audited financials, final dividend of Rs.10 per share (100% on face value), cost auditor ratification at Rs.1.10 lakh plus taxes, appointment of Mr. Saransh Chaudhary as Whole-time Director at Rs.93 lakhs per annum, re-appointment of Dr. Manu Chaudhary as Joint MD at Rs.153.50 lakhs per annum, new Independent Director, and alteration of MOA and AOA. Dividend record date: August 7, 2026.
Routine AGM filing with Rs.10 final dividend and key director appointments. Record date for dividend eligibility is August 7, 2026.